Results 231 to 240 of about 1,588,155 (297)

Dose-Response Association Between Systemic and Dermatologic Glucocorticoid Use and Type 2 Diabetes Mellitus: A Nationwide Case-Control Study. [PDF]

Diabetes Obes Metab
Vadsholt D, Kvist AV, Sandiramoorthy C, Lewis JR, Vestergaard P, Røikjer J, Rasmussen NH.   +6 more
europepmc   +1 more source

Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of "Ozempic Face". [PDF]

Dermatol Ther (Heidelb)
Rao S, Midura I, Mangual KPS, Igel LI, Saunders KH, Carter J, Murase JE, Kourosh AS.   +7 more
europepmc   +1 more source

Hand-Foot Syndrome as a Rare Side Effect of Bleomycin. [PDF]

Pak J Med Sci
Hashmi A, Abid M, Zafar A, Abbas Khokhar M.   +3 more
europepmc   +1 more source

Levodopa and Melanoma: Practical Recommendations for Parkinson's Disease—International Parkinson and Movement Disorder Society Scientific Issues Committee Viewpoint

Movement Disorders Clinical Practice, EarlyView.
Giorgia Sciacca, Inas Elsayed, Santiago Perez‐Lloret, Tiago F. Outeiro, Vivek K. Unni, Jeffery H. Kordower, Daniela Berg, Lorraine V. Kalia, on behalf of the MDS Scientific Issues Committee, Jane Alty, Alexander Balck, Daniela Berg, Per Borghammer, Inas Elsayed, Yue Huang, Walaa Kamel Elsayed, Jeffrey Kordower, Alexander Lehn, Michele Matarazzo, Tiago Mestre, Tiago Outeiro, Gian Pal, Santiago Perez Lloret, Roopa Rajan, Sephira Ryman, Giorgia Sciacca, Per Svenningsson, Lorraine Kalia   +27 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antifungal agents in dermatology

Journal of the American Academy of Dermatology, 1987
Development of new antifungal agents has increased significantly over the past two decades, with recent advances reflecting interest in synthetic agents as opposed to antibiotics. We review the various antifungal medications in use or under development, beginning with a discussion of over-the-counter agents, antibiotics, and older azole compounds and ...
J L, Lesher, J G, Smith
openaire   +2 more sources

Immunosuppressive Agents in Dermatology

Dermatologic Clinics, 1993
Azathioprine, cyclophosphamide, and cyclosporine are immunosuppressive agents commonly used by dermatologists. Azathioprine has a good safety profile and is preferred by most dermatologists for the treatment of bullous pemphigoid, cutaneous vasculitides, chronic eczematous dermatitides, and cutaneous manifestations of connective tissue diseases.
V C, Ho, D M, Zloty
openaire   +2 more sources

Topical Antibacterial Agents in Dermatology

The Journal of Dermatology, 2003
AbstractTopical antibacterials are being widely used for the treatment or prevention of superficial bacterial infections. Emergence of drug resistant mutant strains of microorganisms and development of irritant and allergic contact dermatitis is a common problem with many of the topical antibacterials.
Anjum, Singal, Gurvinder P, Thami
openaire   +2 more sources